The major role of clinicians in the discovery of off-label drug therapies

Pharmacotherapy
Harold J DemonacoEric von Hippel

Abstract

To determine the role of clinicians in the discovery of off-label use of prescription drugs approved by the United States Food and Drug Administration (FDA). Data Sources. Micromedex Healthcare Series was used to identify new uses of new molecular entities approved by the FDA in 1998, literature from January 1999-December 2003 was accessed through MEDLINE, and relevant patents were identified through the U.S. Patent and Trademark Office. A survey of new therapeutic uses for new molecular entity drugs approved in 1998 was conducted for the subsequent 5 years of commercial availability. During that period, 143 new applications were identified in a computerized search of the literature for the 29 new drugs considered and approved in 1998. Literature and patent searches were conducted to identify the first report of each new application. Authors of the seminal articles were contacted through an electronic survey to determine whether they were in fact the originators of the new applications. If they were, examination of article content and author surveys were used to explore if each new application was discovered through clinical practice that was independent of pharmaceutical company or university research (field discovery) or if t...Continue Reading

References

Jan 1, 1992·The Journal of Dermatologic Surgery and Oncology·J D Carruthers, J A Carruthers
Jan 1, 1989·Annales Françaises D'anesthèsie Et De Rèanimation·Y Blanloeil, J C Deybach
Nov 1, 1995·Nature Medicine·R J Wurtman, R L Bettiker
Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Aug 22, 2000·Postgraduate Medicine·R T Brodell
Oct 14, 2000·The New England Journal of Medicine·G W 't JongJ N van den Anker
Jan 4, 2001·American Journal of Preventive Medicine·S E Kellerman, J Herold
Jun 21, 2003·BMJ : British Medical Journal·Jeffrey K Aronson
Feb 27, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Susan G Poole, Michael J Dooley
Oct 29, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jack M RosenbergHoward McGuire
Mar 10, 2005·The Annals of Pharmacotherapy·Mitja KosAles Mrhar
May 3, 2005·Journal of the Royal Society of Medicine·Miles Little

❮ Previous
Next ❯

Citations

Mar 2, 2012·Nature Reviews. Drug Discovery·Jack W ScannellBrian Warrington
Jun 16, 2009·BMC Medical Informatics and Decision Making·Eivind VedvikArild Faxvaag
May 21, 2013·Future Medicinal Chemistry·Stephen M Maurer
Jan 30, 2013·Medical Care·Sheryl Winston Smith, Andrew Sfekas
Aug 13, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Jeana H Frost
Dec 19, 2012·Medicina clínica·Joan Maria Vianney PonsJoaquín Arenas
Jun 1, 2011·Drug Discovery Today·Lixia YaoPankaj Agarwal
Oct 7, 2008·Medical Hypotheses·Alex Tabarrok
Jun 5, 2007·Facial Plastic Surgery Clinics of North America·David Reiter
Oct 21, 2015·Nature Reviews. Clinical Oncology·Francesco BertoliniGauthier Bouche
Jun 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Moon-Chang BaekJong-Sup Bae
Mar 21, 2015·Nature Reviews. Drug Discovery·Eric W EschDongeun Huh
Sep 22, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Tracy E MacaulayWilliam R Vincent
Feb 17, 2009·Orvosi hetilap·András Telekes
Apr 7, 2010·Science Translational Medicine·Bernard H Munos, William W Chin
Sep 3, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Rebecca Dresser, Joel Frader
Mar 21, 2019·Clinical Pharmacology and Therapeutics·David A Shaywitz
Jun 15, 2019·International Journal of Clinical Pharmacy·Shamala BalanVivienne S L Mak
Dec 19, 2019·Expert Opinion on Drug Discovery·Alan Talevi, Carolina L Bellera
Sep 29, 2017·Disability and Rehabilitation. Assistive Technology·Peter D ConradieJelle Saldien
May 1, 2015·Therapeutic Innovation & Regulatory Science·Narcyz GhineaIan Kerridge
May 1, 2015·Therapeutic Innovation & Regulatory Science·Richard W Barker, Jack W Scannell
Aug 11, 2020·Archives of Dermatological Research·Kachiu C LeeLilit Garibyan
Aug 19, 2011·American Journal of Law & Medicine·Coleen Klasmeier, Martin H Redish
Feb 11, 2021·Trends in Pharmacological Sciences·Helen I RoesslerGijs van Haaften
Sep 23, 2021·Science Translational Medicine·C Glenn BegleyMark Sullivan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Internal Medicine
David C RadleyRandall S Stafford
International Journal of Technology Assessment in Health Care
J HuttonChristopher Henshall
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
I Pigeot, J Windeler
© 2021 Meta ULC. All rights reserved